Menu Search
Equities

Health Italia SpA

6I50:FRA

Health Italia SpA

Actions
  • Price (EUR)137.00
  • Today's Change-1.00 / -0.72%
  • Shares traded--
  • 1 Year change+10.04%
  • Beta--
Data delayed at least 15 minutes, as of Jan 28 2025 08:16 GMT.
More ▼
Take Action
Participate in the 2025 Stockpicking Contest
Long or short five stocks and compete to have the highest return by the end of the year.
Choose your picksChoose your picks

Profile data is unavailable for this security.

About the company

Health Italia SpA is an Italy-based company engaged in the healthcare industry. The Company provides medical services, through its subsidiaries and affiliates. Health Italia SpA operates through several entities, including Basis Cliniche Srl, which is specialized in the management of polyclinics and dental centers laboratories; Coopsalute SCpA, which provides welfare and health care services through a network of health professionals and affiliated structures; Scegliere Salute Srl, which deals with the research about healthcare clinics; Impresa Sanitaria Alfa 88 Srl, which runs clinics and nursing homes in the municipality of Rome, and Janua Broker SpA, which is specialized in the business of health care.

  • Revenue in EUR (TTM)37.17m
  • Net income in EUR1.69m
  • Incorporated--
  • Employees101.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.